Stay updated on PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Sign up to get notified when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.

Latest updates to the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse in government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding status notice and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and updates key metadata labels and versioning: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were added while the previous variants Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section expanded with a comprehensive list of sites across US states and Canada, and a Revision: v3.3.3 tag is shown. The HHS Vulnerability Disclosure entry under policy sections was removed.SummaryDifference2%

- Check85 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.0%

- Check92 days agoChange Detected- Page revision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

Stay in the know with updates to PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.